Insulin Analog [EPC]

98568 reported adverse events

Drugs of this class: INSULIN GLARGINE INSULIN LISPRO INSULIN DETEMIR

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 28476
1 BLOOD GLUCOSE DECREASED 6929
2 DRUG INEFFECTIVE 5888
3 INCORRECT DOSE ADMINISTERED 5823
4 DRUG DOSE OMISSION 4003
5 UNDERDOSE 3602
6 NAUSEA 3512
7 HYPOGLYCAEMIA 3448
8 MALAISE 3319
9 VISUAL IMPAIRMENT 3115
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERCEPTED PRODUCT SELECTION ERROR 240 0.5797
1 HYPOGLYCAEMIA UNAWARENESS 130 0.4348
2 ACCIDENTAL UNDERDOSE 973 0.3610
3 ANTI-INSULIN ANTIBODY POSITIVE 72 0.3564
4 INCREASED INSULIN REQUIREMENT 40 0.3175
5 BLOOD KETONE BODY 78 0.3120
6 HYPOGLYCAEMIC UNCONSCIOUSNESS 480 0.2963
7 INSULIN RESISTANCE 269 0.2519
8 HYPOGLYCAEMIC SEIZURE 172 0.2396
9 DIABETIC RETINOPATHY 486 0.2331
See all enriched reactions for Insulin Analog [EPC]